Categories Earnings, Health Care

Mallinckrodt plc (MNK): Q4 2019 Earnings Snapshot

pharma stocks
Image for representation (Photo by Drew Hays on Unsplash)

—  Mallinckrodt plc (NYSE: MNK) reported fourth-quarter 2019 earnings of $2.40 per share, vs. $2.05 per share expected.

— Q4 net sales fell 3.6% to $804.9 million, vs. $772.5 million expected. The topline was helped by strong performance across hospital products and the Specialty Generics segment.

— Company says it has reached an agreement for a global settlement with a broad-based group of plaintiffs that would resolve all opioid-related claims. It would also take actions to address near-term maturities to strengthen capital structure.

 — MNK shares jumped over 20% immediately following the announcement.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

General Motors (GM) fast-tracks EV transition. Is the stock a buy?

General Motors Co. (NYSE: GM) has been ramping up its electric vehicle business, rolling out new models and expanding the production of battery packs. The auto giant’s aggressive EV strategy

Lennar to report Q2 earnings. Will results benefit from demand recovery?

After giving mixed signals in the first half, demand for new homes in the US is expected to recover in the later part of the year. While there is pent-up

Campbell Soup (CPB): A few factors that shaped the Q3 performance

Shares of Campbell Soup Company (NYSE: CPB) stayed red on Monday. The stock has dropped over 8% in the past one month. The food company delivered sales and earnings growth

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top